chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Has had 2 Pneumonia shots and has been sick 3 times this year; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP),. The reporter is the patient.  A 62-year-old female patient received pneumococcal 13-val conj vac (dipht CRM197 protein) (PNEUMOCOCCAL 13-VAL CONJ VAC (DIPHT CRM197 PROTEIN)), as dose 2, single (Batch/Lot number: unknown) for pneumonia, immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Pneumococcal 13-val conj vac (dipht crm197 protein) (Dose 1, single), for immunization. The following information was reported: ILLNESS (non-serious) with onset 2022, outcome "unknown", described as "Has had 2 Pneumonia shots and has been sick 3 times this year".  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I was born in another country and have received the BCG vaccine. The scar from the BCG Vaccine is tender, warm to the touch and bright pink
Nausea; Headache; Weakness; Chills; Feels Off"; Fever; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of NAUSEA (Nausea), HEADACHE (Headache), ASTHENIA (Weakness), CHILLS (Chills) and FATIGUE (Feels Off") in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), Emotrol and ONDANSETRON (ZOFRAN MELT) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), HEADACHE (Headache), ASTHENIA (Weakness), CHILLS (Chills), FATIGUE (Feels Off") and PYREXIA (Fever). At the time of the report, NAUSEA (Nausea), HEADACHE (Headache), ASTHENIA (Weakness), CHILLS (Chills), FATIGUE (Feels Off") and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Minutes after receiving dose, patient felt flushed and dizzy. Generally feeling unwell. Evaluated by medical team immediately and was taken to ED for further evaluation.
Awoke 10/30/13 tired, achy legs, feels "out of it." No rashes. No inflammation at vaccine site. No diff breathing swallowing. T - 98.7.
second dose scheduled on day 90 (June15); fever (post surgery); Chills (post surgery); This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose scheduled on day 90 (June15)), PYREXIA (fever (post surgery)) and CHILLS (Chills (post surgery)) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included Surgery (Hospitalization for cancer surgery) from 07-Apr-2021 to 07-May-2021. Concurrent medical conditions included Cancer since 2018. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) and LACOSAMIDE (VIMPAT) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced PYREXIA (fever (post surgery)) and CHILLS (Chills (post surgery)). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose scheduled on day 90 (June15)). On 28-Apr-2021, PYREXIA (fever (post surgery)) and CHILLS (Chills (post surgery)) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose scheduled on day 90 (June15)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Magnetic resonance imaging: abnormal (abnormal) scheduled surgery for fast-growing tumor..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was hospitalized for cancer surgery on 07-APR-2021 and discharged on 07-MAY-2021  Treatment information included, antibiotics post surgery for two weeks was provided.
Headache & NauseaVomiting  Narrative: Symptoms started evening of injection. Nausea lasted a day, but headache lasted several days.
metal taste; no taste; no smell; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metal taste), AGEUSIA (no taste) and ANOSMIA (no smell) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lung cancer. Concomitant products included PANCREATIN (CREON), LOSARTAN POTASSIUM (COZAAR) and VITAMINS NOS for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced DYSGEUSIA (metal taste), AGEUSIA (no taste) and ANOSMIA (no smell). At the time of the report, DYSGEUSIA (metal taste) had resolved and AGEUSIA (no taste) and ANOSMIA (no smell) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details were reported.
Right after vaccine lips tingled and my vision had a softer focus.  In another hour tongue swelled and it was challenging to talk normally, felt like I had drunk two glasses of wine, vision blurry, strong itching around eyes and neck.  Eye doctor said my vision changed enough to need prescription readers and distance glasses for driving.
Patient received influenza vaccine, waited 10 minutes in store then walked across street to mall where she works. States she "felt weak and weird, like my knees would buckle under me, and felt very nauseated". Continued all day until came back to clinic at 315pm. No shortness of breath or hives or tightness to throat or swelling or itching. Pt. refused EPI-PEN. Referred to ER.
Left armpit lymph node became swollen and sore and lasted about 2 weeks - on or about 9/13/21  Trouble sleeping (feeling "wired" at night) and strange feeling of an electrical charge in legs for the first 2-3 weeks post vaccination.   Tingling pins and needs in feet (Paresthesia) and muscle twitching more pronounced on left side started on 9/23/21 which is still ongoing.  This turned into occasional paresthesia and a burning sensation in left foot after about two months, with decreasing frequency after 3 months.  Most pronounced during mornings and worse in evenings.   Strong feeling of "brain fog" starting on or about 9/20 that lasted about 7 days but returned to normal.   Become slightly sweaty after minimal movement (more than normal pre-vaccine) and feeling warm overall (without fever) particularly in the first 3-4 weeks post vaccination.  Also had very strong thirst (much more than normal) for 4 weeks after vaccination.  However this feeling mostly went away after about 1 month.   Also feel slight leg weakness and leg soreness (mostly left side) that is on and off but is still ongoing, although with decreasing frequency after 3 months.  Arm (deltoid) and calf muscles twitching starting around 9/23  but much more pronounced on left side starting after 3-4 weeks, and occurs with less frequency after 3 months post vaccination.   Starting on or about 11/15/21, starting to have overall general fatigue/exhaustion and feeling as though not being refreshed after a full sleep.  This still occurs after 4+ months and feel that energy level is about 50% of previous pre-vaccination levels.   Also, currently having ongoing trouble concentrating (ie. brain fog) that is off and on.
Pt. felt hot and flushed, she c/o itching of arms and back, also itching of throat but felt it calming down after 10 minutes and drinking water. Her face did appear flushed but she also said it was flushed before she got the injection. No difficulty breathing, no obvious urticaria. She was emotional about losing her mom to anaphylaxis at age 10, stated that her  sister also has similar allergy profile. She questioned if she should et the second vaccine dose.
I was a foot and ankle surgeon in a busy multispecialty clinic in 2006. I worked out of an urgent care and it was a very busy flu year, at times 100 people a day were coming through. Folks would even be laying on the floor waiting to be seen. Out of an abundance of caution someone administratively mandated that everyone in our work area had to get a second booster of influenza that season. I received mine and had a one month steady rapid decline in health with flu like symptoms. The flu symptoms went away but I developed progressive weakness, and almost inability to walk up stairs, cold intolerance, axial and skeletal myopathy of unknown etiology. I had cancer chemo 20 years before and clinic thought it might have been related but no evidence. I was forced to quit doing surgery and eventually over a terrible 1.5 year struggle, I lost my practice, most friends whom were my colleagues and my health. I have piecemealed my life back together and volunteer a couple days a week. No one will hire me of course. I was 47 at the time this all happened. I got to practice about 13 years after my training but the lingering question was this all because of a flu shot gone bad? Numerous specialists could not clearly diagnose and some only admitted in retrospect that it was a partial GBS and has left me with permanent neurological damage.
Moderna COVID-19 Vaccine  On day 9 after the vaccine I have  a 2 inch red rash at the injection site with slight pain. This is new as of today. No prior rash.
t106 morning p/DTP#3; fussy; drinking minimal liquids; unable to dec temp w/APAP; seen @ ER advised to cont; APAP & tepid baths;
Tdap vaccine given on 5/12/15, sore arm evening 5/12/15. 5/13/15 AM-dizziness, joint pain, continued arm soreness. 5/15/15-diarrhea, sinus congestion. Seen in office on 5/19/15-still having sinus congestion. Going to his personal MD. Arm with decreased soreness.
On day 10 I woke with achey shoulders, neck and hands. Later in day had mild chills and overall aches and by evening had 101.5 temp and flushing of face along with mild headache. Tylenol taken along with warm shower and early bed. Woke in am with mild headache, loss of appetite. Felt better by 11am and after a cup of tea. By afternoon I felt 100% back to normal. No rashes or even a sore arm post vaccination in the days prior to this event on day 10.
A week after I took the shout I started experiencing Rash, itchy and a slate warmth on the arm
Patient felt like fainting about 10 mintues after dose.  Sweating,  ears ringing,  .  Patient fell  as a result of dizziness and suffered a few lacerations to arm, bumped his head and complained of pain.   911 was called and patient was sent to Emergency room per ambulance for a checkup.
This spontaneous report as received from a certified medical assistant refers to an unknown number of patients of unknown age and unknown gender. No pertinent medical history, drug reactions or allergies were reported. Since 12-AUG-2014, improperly stored RECOMBIVAX HB was administered to an unknown number of patients (dose, dose number, dose schedule, route, anatomical location, lot number and expiration date were unspecified). No adverse effects were noted. No concomitant therapies were reported. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Grew a lump at vaccination site (right arm). Fluid/pus discharge for first year (was told it was normal) and then lump hardened until excised recently. Biopsy was negative.
pt recvd vax & 29sep exp inc t 103 ax; jerking mvts; v;
She had a palpable nodule at the site of injection of 2cm over the injection site with mild ecchymosis over the area.  She has erythema surrounding the left upper extremity near the injection site measuring about 5 cm in diameter.
now experiencing hair loss even more this morning, whole braid came out/having with my hair loss/ Now I am Balded from left, middle, and on the right side of my head; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (now experiencing hair loss even more this morning, whole braid came out/having with my hair loss/ Now I am Balded from left, middle, and on the right side of my head) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Nose swipe) on 05-Jun-2021. Concurrent medical conditions included Rheumatoid arthritis since 06-Aug-2021, Pre-diabetic since 12-Sep-2015, Allergic reaction to drug (Steglatro), Allergic reaction to drug (Hydroxychloroquine), Allergic reaction to drug (Fenofibrate) and Blood pressure high since 12-Sep-2015. Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL/HCTZ) from 12-Sep-2015 to an unknown date for Blood pressure high, AMITRIPTYLINE from 15-Sep-2016 to an unknown date for Hypertension, PARACETAMOL (TYLENOL [PARACETAMOL]) for Pain, METFORMIN from 12-Sep-2015 to an unknown date for Pre-diabetic, LEFLUNOMIDE from 06-Aug-2021 to an unknown date for Rheumatoid arthritis, COLECALCIFEROL (VITAMIN D3), CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]), BIOTIN and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 13-Dec-2021 at 1:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Dec-2021, the patient experienced ALOPECIA (now experiencing hair loss even more this morning, whole braid came out/having with my hair loss/ Now I am Balded from left, middle, and on the right side of my head). At the time of the report, ALOPECIA (now experiencing hair loss even more this morning, whole braid came out/having with my hair loss/ Now I am Balded from left, middle, and on the right side of my head) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient experiencing hair loss. She started noticing it a couple of days ago and even more in the morning on the day of reporting. Her natural hair was braided. Her whole braid came out.  No treatment information details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Dec-2021: Significant Follow Up received updated Patient demographic information and History conditions, Concomitant medication dose details, Anatomical location, AE onset date Updated.
Chills; nausea; body aches; headache; fatigue; This is a spontaneous report from a contactable consumer (patient, self-reported). A 23-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247 and expiration date was not reported), via an unspecified route of administration in left arm on 17Feb2021 at 10:15 AM, at single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. Historical vaccine included a first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3247 and expiration date was not reported) via an unspecified route of administration in left arm on 27Jan2021 at 10:30 am at single dose for COVID-19 immunisation. It reported that, on 18Feb2021 after receiving the vaccination the patient experienced Chills, nausea, body aches, headache, fatigue. Vaccination facility: Workplace clinic. The patient did not receive any of the vaccine in four weeks and any of the medications in two weeks. No COVID prior vaccination and no COVID tested post vaccination. The outcome of the patient's events was not recovered.
He died suddenly on May 13th.  Had just had thorough physical prior to vaccines.  Perfect health, weight perfect.  No prior health concerns.  Heart attack or stroke in his yard.  After his first dose on March 16, 2021 he ceased his several mile walk each day stating he was tired and lethargic.  He was a military man that rose each day of his life to that walk.  His second dose was 04/16/21 he still did not continue the walks and on May 13, 2021 died suddenly of heart attack or stroke.
Moderna vaccine was administered outside of facility - reported by patient ? NO LOT NUMBER WERE SUPPLIED ----------------------------------------------------------------------------------------------------------------- T78.2XXA ANAPHYLAXIS, INIT 6/19/2022 UTERINE FIBROIDS
Middle of the night 12/22/21- Left chest pain and shortness of breath. Hard to breathe unless sitting up completely. Very difficult to breathe lying down, even with head and chest elevated to 60 degrees. Could not breathe when laying on either side. Visit to Urgent Care, Primary Care Physician, and ER all that day. Prescribed antibiotics and steroids. Chest pain resided in a few days with treatment. Follow up Echocardiogram and chest X-ray recommended.
Day of it started becoming extremely sore about 6 hours after given. By that evening, I was not able to put any pressure  on arm. The next day was more of the same with then two raised, hard areas that formed on upper arm. The 3rd day, the upper arm broke out in a heated rash that lasted for another two days. On the 3rd day, I also had soreness, to the touch, that occurred on a scar on my back where I had recent surgery. By the 6th day, the soreness on my back and arm subsided and the heat to the rash went away but the rash remained. There is still a slight redness on my upper left arm but no pain or heat.
This spontaneous report as received from a physician via a company representative refers to a 15 year old female patient with no known allergies. No pertinent medical history was provided. On 10-JUL-2013, the patient was vaccinated with the first dose of GARDASIL inj (dose, route and lot number not provided). On 14-SEP-2013, the patient received the second dose of GARDASIL, and on 30-JAN-2014 the patient received the third dose of GARDASIL (doses, routes and lot numbers not provided). No co-suspect or concomitant therapies were provided. The physician reported that the patient was admitted to a hospital on 06-JUL-2014 for unspecified symptoms. The patient tested positive for parvovirus (date not provided, approximately in 2014). The patient was also diagnosed with mild myositis (date not provided, approximately in 2014). The physician stated that the patient was unable to walk at some point during her hospitalization as a result of the myositis which was a significant disability (date not provided, approximately in 2014). The patient was discharged from the hospital on an unspecified date (approximately in 2014). The patient also saw an unspecified Neurologist and Rheumatologist on unspecified dates. On an unspecified date, approximately in 2014, the patient was in recovery according to information received by the primary care physician from the neurologist. The reporting physician considered the events "The patient was also diagnosed with mild myositis" and "The patient was unable to walk at some point during her hospitalization" as disability events. Additional information is not expected because there was no consent to follow-up with the reporting physician.
pt stated she had a tingle in her arm and was feeling dizzy.  I laid her down and propped her legs up and put a cold water bottle behind her neck.  She said her left arm was tingling so we called 911 and I continued to monitor her until EMS arrived.  She never lost conscience or alertness.  Pt was able to carry on a conversation.  Her breathing did get more labored and intense.  She said she was trying her Yoga breathing technique due to having panic attacks in the past.  She was released to EMS
Itching all over body. No rash, bites or bumps. Only itching.
Paxlovid as COVID-19 Treatment; Paxlovid as COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 61 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 24Dec2020 as dose 1, single (Batch/Lot number: unknown), in left arm, on 15Jan2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 14Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 20Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing). The patient has no known allergies. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Paxlovid as COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Negative, notes: After taking Paxlovid; Positive again after negative. Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid given on an unspecified date..  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2 to the vaccination failure (LOE) and covid 19  cannot be ruled out.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. No concurrent conditions, medical history, concomitant medications and drug allergies were reported. On 18-JUN-2015, the patients were vaccinated with a dose of improperly stored PROQUAD (Merck) (lot number reported as L005297, expiration date: 17-AUG-2016) (dose and route not reported). No adverse effects were reported. Lot number L005297 has been verified to be a valid lot number for PROQUAD (Merck). Follow up information has been received on 03-AUG-2015 that all telephone attempts to obtain follow-up information have been unsuccessful. Follow-up information was received on 05-AUG-2015. The reporting certified medical assistant would have to search the request made for patients' identifiers, lot numbers and expiration dates and dates of vaccination. Follow-up information was received from the medical assistant's clinic on 22-OCT-2015, regarding a 4-year-old patient of unknown gender, On 21-AUG-2015, the patient was vaccinated with a dose of improperly stored PROQUAD (Merck). This is one of several reports received from the same source. Additional information has been requested. Patient, product, event information and narrative were updated.
Patient called saying her left shoulder hurting since Friday 9/14 after shot was given. Feels like pinched nerves in her neck as well. Asked patient if she took an NSAID? Patient said she doesn't have any at home. She will start next Monday 9/24/18 when she comes into the store. Follow up call placed 9/22/18 and 9/23/18. Left message and no answer 2nd call.